245 related articles for article (PubMed ID: 17391982)
41. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
42. E3 ligases in T cell anergy--turning immune responses into tolerance.
Heissmeyer V; Rao A
Sci STKE; 2004 Jul; 2004(241):pe29. PubMed ID: 15252218
[TBL] [Abstract][Full Text] [Related]
43. E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia.
Liu L; Xiang Y; Shao L; Yuan C; Song X; Sun M; Liu Y; Zhang X; Du S; Hou M; Peng J; Shi Y
J Thromb Haemost; 2024 Apr; 22(4):1202-1214. PubMed ID: 38184203
[TBL] [Abstract][Full Text] [Related]
44. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells.
Qu JL; Qu XJ; Qu JL; Qu XJ; Zhao MF; Teng YE; Zhang Y; Hou KZ; Jiang YH; Yang XH; Liu YP
Acta Oncol; 2009; 48(8):1173-80. PubMed ID: 19863226
[TBL] [Abstract][Full Text] [Related]
45. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy.
Kumar S; Naqvi RA; Khanna N; Rao DN
Mol Immunol; 2011 May; 48(9-10):1178-90. PubMed ID: 21453975
[TBL] [Abstract][Full Text] [Related]
46. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of the Cbl family of E3 ubiquitin ligases decreases Interleukin-2 production in a rat model of peripheral neuropathy.
Jeong JS; Kim HY; Shin BS; Lee AR; Yoon JH; Hahm TS; Lee JE
BMC Anesthesiol; 2018 Jul; 18(1):87. PubMed ID: 30021515
[TBL] [Abstract][Full Text] [Related]
48. Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
Mfuh AM; Boerth JA; Bommakanti G; Chan C; Chinn AJ; Code E; Fricke PJ; Giblin KA; Gohlke A; Hansel C; Hariparsad N; Hughes SJ; Jin M; Kantae V; Kavanagh SL; Lamb ML; Lane J; Moore R; Puri T; Quinn TR; Reddy I; Robb GR; Robbins KJ; Gancedo Rodrigo M; Schimpl M; Singh B; Singh M; Tang H; Thomson C; Walsh JJ; Ware J; Watson IDG; Ye MW; Wrigley GL; Zhang AX; Zhang Y; Grimster NP
J Med Chem; 2024 Jan; 67(2):1500-1512. PubMed ID: 38227216
[TBL] [Abstract][Full Text] [Related]
49. E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination.
Zhao Y; Guo H; Qiao G; Zucker M; Langdon WY; Zhang J
J Immunol; 2015 Feb; 194(4):1639-45. PubMed ID: 25560411
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1.
Kojo S; Elly C; Harada Y; Langdon WY; Kronenberg M; Liu YC
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17847-51. PubMed ID: 19815501
[TBL] [Abstract][Full Text] [Related]
51. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.
Fang D; Wang HY; Fang N; Altman Y; Elly C; Liu YC
J Biol Chem; 2001 Feb; 276(7):4872-8. PubMed ID: 11087752
[TBL] [Abstract][Full Text] [Related]
52. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
Veselits M; Tanaka A; Lipkowitz S; O'Neill S; Sciammas R; Finnegan A; Zhang J; Clark MR
PLoS One; 2014; 9(3):e89792. PubMed ID: 24651487
[TBL] [Abstract][Full Text] [Related]
53. Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice.
Wohlfert EA; Callahan MK; Clark RB
J Immunol; 2004 Jul; 173(2):1059-65. PubMed ID: 15240694
[TBL] [Abstract][Full Text] [Related]
54. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
[TBL] [Abstract][Full Text] [Related]
55. Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.
Xiao Y; Qiao G; Tang J; Tang R; Guo H; Warwar S; Langdon WY; Tao L; Zhang J
J Immunol; 2015 Nov; 195(9):4218-27. PubMed ID: 26416283
[TBL] [Abstract][Full Text] [Related]
56. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
[TBL] [Abstract][Full Text] [Related]
57. Cbl E3 Ligase Mediates the Removal of Nectin-1 from the Surface of Herpes Simplex Virus 1-Infected Cells.
Deschamps T; Dogrammatzis C; Mullick R; Kalamvoki M
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381567
[TBL] [Abstract][Full Text] [Related]
58. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.
Vos WG; van Os BW; den Toom M; Beckers L; van Roomen CPAA; van Tiel CM; Mohapatra BC; Band H; Nitz K; Weber C; Atzler D; de Winther MPJ; Bosmans LA; Lutgens E; Seijkens TTP
Front Immunol; 2024; 15():1297893. PubMed ID: 38504977
[TBL] [Abstract][Full Text] [Related]
59. B cell receptor-mediated antigen gathering requires ubiquitin ligase Cbl and adaptors Grb2 and Dok-3 to recruit dynein to the signaling microcluster.
Schnyder T; Castello A; Feest C; Harwood NE; Oellerich T; Urlaub H; Engelke M; Wienands J; Bruckbauer A; Batista FD
Immunity; 2011 Jun; 34(6):905-18. PubMed ID: 21703542
[TBL] [Abstract][Full Text] [Related]
60. Molecular regulation of T-cell anergy.
Zheng Y; Zha Y; Gajewski TF
EMBO Rep; 2008 Jan; 9(1):50-5. PubMed ID: 18174897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
